生物可吸收支架(BAS)的开发平台 - 开发阶段，市场区隔，地区和国家，法规途径，主要企业(2023年版)

Bioabsorbable Stents (BAS) Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日期: 2023年04月19日 | 出版商:

GlobalData | 英文 111 Pages | 订单完成后即时交付

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

本报告提供生物可吸收支架(BAS)的开发中产品调查分析，包含各开发阶段产品的比较分析，及进行中的临床试验相关之全面性资讯。

Abbott Vascular Inc，企业概要
- Abbott Vascular Inc，开发中产品和进行中的临床试验概要
Amaranth Medical Inc，企业概要
- Amaranth Medical Inc，开发中产品和进行中的临床试验概要
Arterius Ltd，企业概要
- Arterius Ltd，开发中产品和进行中的临床试验概要
Biosensors International Group Ltd，企业概要
- Biosensors International Group Ltd，开发中产品和进行中的临床试验概要
Biosten, LLC，企业概要
- Biosten, LLC，开发中产品和进行中的临床试验概要
Biotronik AG，企业概要
- Biotronik AG，开发中产品和进行中的临床试验概要
Biotronik SE & Co KG，企业概要
- Biotronik SE & Co KG，开发中产品和进行中的临床试验概要
Biotyx Medical (深圳) Co Ltd，企业概要
- Biotyx Medical (深圳) Co Ltd，开发中产品和进行中的临床试验概要
Boston Scientific Corp，企业概要
- Boston Scientific Corp，开发中产品和进行中的临床试验概要
Cardionovum GmbH，企业概要
- Cardionovum GmbH，开发中产品和进行中的临床试验概要
Cordis Corp，企业概要
- Cordis Corp，开发中产品和进行中的临床试验概要
HangZhou HuaAn Biotechnology Co., Ltd.，企业概要
- HangZhou HuaAn Biotechnology Co., Ltd.，开发中产品和进行中的临床试验概要
Icon Interventional Systems, Inc.，企业概要
- Icon Interventional Systems, Inc.，开发中产品和进行中的临床试验概要
Japan Stent Technology Co., Ltd.，企业概要
- Japan Stent Technology Co., Ltd.，开发中产品和进行中的临床试验概要
Kyoto Medical Planning Co Ltd，企业概要
- Kyoto Medical Planning Co Ltd，开发中产品和进行中的临床试验概要
Lifetech Scientific (深圳) Co Ltd，企业概要
- Lifetech Scientific (深圳) Co Ltd，开发中产品和进行中的临床试验概要
Manli Cardiology Ltd，企业概要
- Manli Cardiology Ltd，开发中产品和进行中的临床试验概要
Meril Life Sciences Pvt Ltd，企业概要
- Meril Life Sciences Pvt Ltd，开发中产品和进行中的临床试验概要
Micell Technologies Inc，企业概要
- Micell Technologies Inc，开发中产品和进行中的临床试验概要
Michigan Technological University，企业概要
- Michigan Technological University，开发中产品和进行中的临床试验概要
MicroPort Scientific Corp，企业概要
- MicroPort Scientific Corp，开发中产品和进行中的临床试验概要
Minvasys SAS，企业概要
- Minvasys SAS，开发中产品和进行中的临床试验概要
MIV Therapeutics Inc，企业概要
- MIV Therapeutics Inc，开发中产品和进行中的临床试验概要
NanoCoeur, Inc.，企业概要
- NanoCoeur, Inc.，开发中产品和进行中的临床试验概要
North Carolina State University，企业概要
- North Carolina State University，开发中产品和进行中的临床试验概要
Northwestern University，企业概要
- Northwestern University，开发中产品和进行中的临床试验概要
OrbusNeich，企业概要
- OrbusNeich，开发中产品和进行中的临床试验概要
Pediastent LLC，企业概要
- Pediastent LLC，开发中产品和进行中的临床试验概要
QualiMed Innovative Medizinprodukte GmbH，企业概要
- QualiMed Innovative Medizinprodukte GmbH，开发中产品和进行中的临床试验概要
REVA Medical Inc，企业概要
- REVA Medical Inc，开发中产品和进行中的临床试验概要
S3v Vascular Technologies，企业概要
- S3v Vascular Technologies，开发中产品和进行中的临床试验概要
Shanghai Bio-heart Biological Technology Co Ltd，企业概要
- Shanghai Bio-heart Biological Technology Co Ltd，开发中产品和进行中的临床试验概要
Shanghai Healing Medical Instruments Co Ltd，企业概要
- Shanghai Healing Medical Instruments Co Ltd，开发中产品和进行中的临床试验概要
Tepha Inc，企业概要
- Tepha Inc，开发中产品和进行中的临床试验概要
Tremedics Medical Devices LLC，企业概要
- Tremedics Medical Devices LLC，开发中产品和进行中的临床试验概要
UAB Minority Health and Health Equity Research Center，企业概要
- UAB Minority Health and Health Equity Research Center，开发中产品和进行中的临床试验概要
University of Florida，企业概要
- University of Florida，开发中产品和进行中的临床试验概要
University of Strathclyde，企业概要
- University of Strathclyde，开发中产品和进行中的临床试验概要
VasoTech Inc.，企业概要
- VasoTech Inc.，开发中产品和进行中的临床试验概要
Xenogenics Corporation，企业概要
- Xenogenics Corporation，开发中产品和进行中的临床试验概要

第6章生物可吸收支架(BAS) - 最近的开发

第7章附录

简介目录

Product Code: GDME1519EPD

Abstract

GlobalData's Medical Devices sector report, "Bioabsorbable Stents (BAS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Bioabsorbable Stents (BAS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bioabsorbable stents are also known as bioreabsorbable or biodegradable coronary stents. The advantage of this stent is that it does not leave any metal body behind and hence, the possibility of late-stent thrombosis and restenosis decreases. Bioabsorbable stents help in better drug delivery compared to metallic stents.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Bioabsorbable Stents (BAS) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Bioabsorbable Stents (BAS) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Bioabsorbable Stents (BAS) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Bioabsorbable Stents (BAS) Overview

3 Products under Development

3.1 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
3.2 Bioabsorbable Stents (BAS) - Pipeline Products by Territory
3.3 Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
3.4 Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date
3.5 Bioabsorbable Stents (BAS) - Ongoing Clinical Trials

4 Bioabsorbable Stents (BAS) - Pipeline Products under Development by Companies

4.1 Bioabsorbable Stents (BAS) Companies - Pipeline Products by Stage of Development
4.2 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development

5 Bioabsorbable Stents (BAS) Companies and Product Overview

5.1 Abbott Vascular Inc Company Overview
- 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Amaranth Medical Inc Company Overview
- 5.2.1 Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Arterius Ltd Company Overview
- 5.3.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.4 Biosensors International Group Ltd Company Overview
- 5.4.1 Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Biosten, LLC Company Overview
- 5.5.1 Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 Biotronik AG Company Overview
- 5.6.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
5.7 Biotronik SE & Co KG Company Overview
- 5.7.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
5.8 Biotyx Medical (Shenzhen) Co Ltd Company Overview
- 5.8.1 Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Boston Scientific Corp Company Overview
- 5.9.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Cardionovum GmbH Company Overview
- 5.10.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.11 Cordis Corp Company Overview
- 5.11.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.12 HangZhou HuaAn Biotechnology Co., Ltd. Company Overview
- 5.12.1 HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Icon Interventional Systems, Inc. Company Overview
- 5.13.1 Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Japan Stent Technology Co., Ltd. Company Overview
- 5.14.1 Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.15 Kyoto Medical Planning Co Ltd Company Overview
- 5.15.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
- 5.16.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Manli Cardiology Ltd Company Overview
- 5.17.1 Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.18 Meril Life Sciences Pvt Ltd Company Overview
- 5.18.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.19 Micell Technologies Inc Company Overview
- 5.19.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Michigan Technological University Company Overview
- 5.20.1 Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview
5.21 MicroPort Scientific Corp Company Overview
- 5.21.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.22 Minvasys SAS Company Overview
- 5.22.1 Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview
5.23 MIV Therapeutics Inc Company Overview
- 5.23.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 NanoCoeur, Inc. Company Overview
- 5.24.1 NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.25 North Carolina State University Company Overview
- 5.25.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
5.26 Northwestern University Company Overview
- 5.26.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.27 OrbusNeich Company Overview
- 5.27.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
5.28 Pediastent LLC Company Overview
- 5.28.1 Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview
5.29 QualiMed Innovative Medizinprodukte GmbH Company Overview
- 5.29.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.30 REVA Medical Inc Company Overview
- 5.30.1 REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 S3V Vascular Technologies Company Overview
- 5.31.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.32 Shanghai Bio-heart Biological Technology Co Ltd Company Overview
- 5.32.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 Shanghai Healing Medical Instruments Co Ltd Company Overview
- 5.33.1 Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 Tepha Inc Company Overview
- 5.34.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Tremedics Medical Devices LLC Company Overview
- 5.35.1 Tremedics Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
5.36 UAB Minority Health and Health Equity Research Center Company Overview
- 5.36.1 UAB Minority Health and Health Equity Research Center Pipeline Products & Ongoing Clinical Trials Overview
5.37 University of Florida Company Overview
- 5.37.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.38 University of Strathclyde Company Overview
- 5.38.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
5.39 VasoTech Inc. Company Overview
- 5.39.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.40 Xenogenics Corporation Company Overview
- 5.40.1 Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview

6 Bioabsorbable Stents (BAS)- Recent Developments

6.1 Mar 08, 2023: OrbusNeich Announces Record Revenue of US$136.8 Million, Adjusted Net Profit Up 25% to US$26.7 Million
6.2 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
6.3 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
6.4 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022
6.5 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
6.6 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
6.7 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022